These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3091077)

  • 21. Urokinase-type and tissue-type plasminogen activators have different distributions in cultured bovine capillary endothelial cells.
    Moscatelli D
    J Cell Biochem; 1986; 30(1):19-29. PubMed ID: 3082899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The fast-acting inhibitor of tissue-type plasminogen activator in plasma is also the primary plasma inhibitor of urokinase.
    Kruithof EK; Tran-Thang C; Bachmann F
    Thromb Haemost; 1986 Feb; 55(1):65-9. PubMed ID: 3085266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells.
    Gelehrter TD; Sznycer-Laszuk R
    J Clin Invest; 1986 Jan; 77(1):165-9. PubMed ID: 2418059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid inactivation of the plasminogen-activator inhibitor upon secretion from cultured human endothelial cells.
    Kooistra T; Sprengers ED; van Hinsbergh VW
    Biochem J; 1986 Nov; 239(3):497-503. PubMed ID: 3103601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secretion of plasminogen activator inhibitor by cultured human epidermal cells.
    Hashimoto K; Nishioka K; Katayama I; Yoshikawa K
    Br J Dermatol; 1986 Aug; 115(2):133-8. PubMed ID: 3091060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification.
    Nielsen LS; Andreasen PA; Grøndahl-Hansen J; Huang JY; Kristensen P; Danø K
    Thromb Haemost; 1986 Apr; 55(2):206-12. PubMed ID: 3520936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and characterization of a plasminogen activator secreted by a pig kidney cell line.
    Sudol M; Reich E
    Biochem J; 1984 May; 219(3):971-8. PubMed ID: 6430276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoaffinity purification of HTC rat hepatoma cell plasminogen activator-inhibitor-1.
    Zeheb R; Rafferty UM; Rodriguez MA; Andreasen P; Gelehrter TD
    Thromb Haemost; 1987 Dec; 58(4):1017-23. PubMed ID: 3127913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators.
    Levin EG; Loskutoff DJ
    J Cell Biol; 1982 Sep; 94(3):631-6. PubMed ID: 6813340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A sensitive assay, specific for endothelial cell type plasminogen activator inhibitor in blood plasma.
    Sprengers ED
    Thromb Haemost; 1986 Feb; 55(1):74-7. PubMed ID: 3085268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human leucocyte urokinase inhibitor--purification, characterization and comparative studies against different plasminogen activators.
    Kopitar M; Rozman B; Babnik J; Turk V; Mullins DE; Wun TC
    Thromb Haemost; 1985 Dec; 54(4):750-5. PubMed ID: 3879018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasminogen activators catalyse conversion of inhibitor from fibrosarcoma cells to an inactive form with a lower apparent molecular mass.
    Nielsen LS; Andreasen PA; Grøndahl-Hansen J; Skriver L; Danø K
    FEBS Lett; 1986 Feb; 196(2):269-73. PubMed ID: 3081367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and characterization of a tissue plasminogen activator-inhibitor complex from human umbilical vein endothelial cell conditioned medium.
    Sanzo MA; Marasa JC; Wittwer AJ; Siegel NR; Harakas NK; Feder J
    Biochemistry; 1987 Nov; 26(23):7443-9. PubMed ID: 3122830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator.
    Astedt B; Lecander I; Brodin T; Lundblad A; Löw K
    Thromb Haemost; 1985 Feb; 53(1):122-5. PubMed ID: 3922076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and partial characterization of a plasminogen activator inhibitor from the human glioblastoma, U138.
    Rehemtulla A; Murphy P; Dobson M; Hart DA
    Biochem Cell Biol; 1988 Dec; 66(12):1270-7. PubMed ID: 3149898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor.
    Nachman RL; Hajjar KA; Silverstein RL; Dinarello CA
    J Exp Med; 1986 Jun; 163(6):1595-600. PubMed ID: 3086483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells.
    van Mourik JA; Lawrence DA; Loskutoff DJ
    J Biol Chem; 1984 Dec; 259(23):14914-21. PubMed ID: 6438106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human articular cartilage contains an inhibitor of plasminogen activator.
    Yamada H; Stephens RW; Nakagawa T; McNicol D
    J Rheumatol; 1988 Jul; 15(7):1138-43. PubMed ID: 3139880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin, and histamine.
    Hanss M; Collen D
    J Lab Clin Med; 1987 Jan; 109(1):97-104. PubMed ID: 3098881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human hepatoma cell line plasminogen activator.
    Levin EG; Fair DS; Loskutoff DJ
    J Lab Clin Med; 1983 Oct; 102(4):500-8. PubMed ID: 6311924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.